Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant anti-PD-1 humanized monoclonal antibody in advanced malignancies
CTR20191892Phase 2Completed
- Sponsor
- Anke Bio
- Start
- Jan 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of anti-PD-1 humanized monoclonal antibody in Non-hematologic malignancy, lymphoma, sponsored by Anke Bio. Started Jan 2020; status: completed.
02
Drugs
anti-PD-1 humanized monoclonal antibody
03
Conditions
Non-hematologic malignancylymphoma
Beyond the preview
Go deeper on CTR20191892.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20191892.